[Gene therapy for primary immunodeficiency]

Area of Science:

• * Molecular biology and genetic medicine.
• * Focus on gene therapy for inherited diseases.

Background:

• * Traditional gene therapy involves adding functional genes to correct genetic disorders, particularly effective for single-gene defects like primary immunodeficiency disorders (PID).
• * A significant drawback of gene addition is insertional mutagenesis, leading to leukemogenesis, limiting its application for gain-of-function mutations.

Purpose of the Study:

• * To review the current status of gene addition therapy for PID.
• * To explore the future potential of gene correction techniques in PID treatment.

Main Methods:

• * Literature review and analysis of gene therapy strategies.
• * Discussion of gene addition versus gene correction mechanisms.

Main Results:

• * Gene addition has shown clinical effects for PID but carries risks of cancer due to mutagenesis.
• * Gene correction techniques are emerging as a promising alternative to overcome the limitations of gene addition.

Conclusions:

• * Gene correction represents the next frontier in gene therapy for PID, offering improved safety and efficacy.
• * Advancements in gene correction are crucial for developing safer and more effective treatments for genetic disorders.